Company intelligence / Profile preview

Pinnacle IVD

United States

Ownership: Private
Development stage: Other

Overview

Pinnacle BioLabs is a leading U.S. manufacturer of rapid, point-of-care, and at-home in vitro diagnostics for colorectal cancer screening, drug of abuse testing, and general health monitoring. Their Second Generation FIT® colon cancer test is the top-selling OTC colon cancer test in North America. They are expanding into additional at-home and direct-to-consumer diagnostic categories.

Therapeutic areas: CardiovascularImmunologyEndocrinologyGastroenterologyInfectious DiseasesMen's HealthPsychiatryOncology
Modalities: Diagnostic test kitUrinalysis deviceAt-home lab test device
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Pinnacle IVD.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pinnacle IVD.

Explore the full profile